Metoprolol Dosing for Supraventricular Tachycardia
For acute SVT in adults without contraindications, administer metoprolol tartrate 2.5–5.0 mg IV bolus over 2 minutes, repeating every 10 minutes up to 3 doses (maximum 15 mg total), followed by oral metoprolol 25–100 mg every 6–12 hours for ongoing management. 1
Acute IV Dosing
The 2015 ACC/AHA/HRS guideline provides Class IIa recommendation for intravenous beta blockers (including metoprolol) as reasonable for acute treatment in hemodynamically stable patients with AVNRT and other SVTs 1, 2. The specific dosing protocol is:
- Initial dose: 2.5–5.0 mg IV bolus administered over 2 minutes
- Repeat dosing: Can repeat 2.5–5.0 mg IV bolus every 10 minutes
- Maximum: Up to 3 total doses (7.5–15 mg cumulative) 1
This dosing strategy has demonstrated efficacy in multiple studies, with conversion to sinus rhythm occurring in 57% of patients with paroxysmal atrial tachycardia and significant heart rate reduction in those who don't convert 3. The electrophysiologic effects include 20% prolongation of sinus cycle length and 34% increase in AH interval, effectively slowing AV nodal conduction 4.
Monitoring During IV Administration
During intravenous administration, continuously monitor:
- Blood pressure (watch for hypotension)
- Heart rate (assess for excessive bradycardia)
- Electrocardiogram (monitor for heart block) 5
The drug is generally well tolerated, with peak electrophysiologic effect occurring at serum concentrations around 54.6 ng/mL 4.
Oral Dosing for Ongoing Management
After successful acute treatment or for chronic management, the guideline gives Class I recommendation for oral beta blockers in patients not pursuing catheter ablation 2:
- Initial dose: 25–50 mg every 6–12 hours
- Maintenance dose: Typically 50–100 mg twice daily
- Titration: Adjust based on heart rate control and tolerability
For patients who received full IV dosing (15 mg), initiate oral metoprolol 50 mg every 6 hours starting 15 minutes after the last IV dose 5. In patients with partial IV tolerance, start with 25 mg every 6 hours.
Important Clinical Considerations
Metoprolol vs. Other Beta-Blockers: The evidence suggests metoprolol has similar electrophysiologic potency to propranolol but offers beta-1 selectivity, making it preferable when concerns about bronchospasm exist 4. However, one study noted that metoprolol-induced AV block persisted or recurred in 24 of 36 cases (67%), compared to better outcomes with carvedilol 6, suggesting careful monitoring is warranted.
Comparative Effectiveness: While some evidence suggests diltiazem may achieve faster rate control in atrial fibrillation with RVR 7, this may relate to dosing strategies (weight-based diltiazem vs. flat-dose metoprolol) rather than true superiority. The studies comparing weight-based metoprolol to diltiazem are underpowered with only 94 total patients 7.
Special Populations:
- Elderly patients: Start with lower doses (2.5 mg IV, 25 mg oral) due to decreased hepatic/renal function 5
- Hepatic impairment: Initiate at low doses with cautious titration, as blood levels increase substantially 5
- Renal impairment: No dose adjustment required 5
Common Pitfalls to Avoid
- Administering too rapidly: The 2-minute infusion time for IV boluses is critical to avoid precipitous hypotension
- Inadequate monitoring: Hypotension and bradycardia are the most common adverse effects requiring continuous surveillance 1
- Using in decompensated heart failure: This is an absolute contraindication for acute IV administration 1
- Ignoring drug interactions: Metoprolol combined with other AV nodal blocking agents (diltiazem, verapamil, digoxin) increases risk of heart block 1